The Goldman Sachs Group, Inc. GS is on track for a historic year in mergers and acquisitions (M&A), potentially not seen since the early 2000s, as deal-making accelerates. GS has continued to maintain ...

The biotech sector, represented by the iShares Biotechnology ETF, has experienced a notable rally in recent months. The key driver of the 40% over the past six months has been a notable uptick in M&A ...

In the third quarter of 2025, the transport sector witnessed a continued decline in merger and acquisition (M&A) activity, marking the third consecutive quarter of reduced deal volume. This downward ...

Goldman Sachs is capitalizing on a dealmaking renaissance that hasn’t been seen in nearly a quarter-century. As mergers and acquisitions activity surges globally, the Wall Street powerhouse has ...